4 employees
mFluiDx focuses on the development of technology solutions to diagnose pandemics and offers a DNA diagnostic test.
2016
mFluiDx raised undisclosed on March 1, 2020
Investors: Berkeley SkyDeck
mFluiDx raised undisclosed on March 8, 2016
Investors: IndieBio and SOSV - The Accelerator VC